-
News
- Technology /AI
- Medical journals
- Topics
Rheumatic Diseases
We recommend
Bimekizumab in the Treatment of Psoriatic Arthritis
20. 6. 2024 Source: Rheumatic DiseasesArthritis can appear in up to a third of patients with psoriasis, mostly after the onset of skin symptoms. Early recognition of this transition by dermatologists and general practitioners is crucial, as early intervention can prevent irreversible joint damage. In the context of effective biological therapy, there is even talk of the potential prevention of arthritis development in individuals with psoriasis.
With Dr. Miroslav Nečas, Ph.D., on the conclusions of the recent consensus of the expert panel on the practice of biological treatment of psoriasis
This February, an expert consensus on the use of bimekizumab in the treatment of psoriasis and…19. 6. 2024 Source: Rheumatic Diseases
Dual Inhibition of IL-17A/IL-17F Across the Spectrum of Axial Spondyloarthritis
Many patients with axial spondyloarthritis (axSpA) still have a need to seek additional therapeutic…1. 12. 2023 Source: Rheumatic Diseases
No content is currently available on this topic.Most read on this topic- Dual Inhibition of IL-17A/IL-17F Across the Spectrum of Axial Spondyloarthritis
- Bimekizumab in the Treatment of Psoriatic Arthritis
- With Dr. Miroslav Nečas, Ph.D., on the conclusions of the recent consensus of the expert panel on the practice of biological treatment of psoriasis
Interesting linksLogin#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Technology /AI